AMN Healthcare Services is classed by the SEC under Services-Help Supply Services (industry code 7363), based in Dallas, TX. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.7 billion and a loss of $96 million (its filed statements).
Brokerage businessServices-Help Supply ServicesDallas, TXfilings since 20019 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a brokerage business: prior from its industry code (SEC 7363, Services-Help Supply Services); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.2 out of ten, 9 of 9 metrics filed: past 6.1 out of ten, present 3.4 out of ten, future 4.0 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 7.2 out of ten. No warning events in its filings since 2017. 72nd percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 4.6 out of ten. +4.1% a year over 10 filed years; profitable in 8 of 10. 46th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 6.3 out of ten. Share count shrank 5.0% a year. 44% of cash flow returned. Insiders: 2 sales, 0 purchases. 63rd percentile among 14 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 3.1 out of ten. ROE -15%: lost 15¢ per shareholder dollar. Leverage 69%: owes 69¢ per asset dollar. 31st percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 3.6 out of ten. bottom 36% of 18 in its family; net margin -3.5%. 36th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 3.3 out of ten. bottom 32% of 16 in its family for leadership; chief executive since 2022. 32nd percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 5.9 out of ten. top 41% of 17 in its family for room to expand. 59th percentile among 17 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 1.6 out of ten. bottom 16% of 18 in its family for growth drivers. 16th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 4.4 out of ten. bottom 44% of 17 in its family for expectations against reality. 44th percentile among 17 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-20 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-07 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2025-11-06 (on EDGAR). Newest filing: Form 4, 2026-09-16. Filings on record since 2001. Read from EDGAR 2026-10-12.
Where the revenue comes from
Lines of business in fiscal 2025: Nurse and Allied Healthcare Staffing 60%, Physician and Leadership Solutions 26%, Technology and Workforce Solutions 14%. As tagged in its annual report (Form 10-K, filed 2026-02-20).
Who runs it
Grace, Caroline (Chief Executive Officer); Scott, Brian M. (CFO/COO); Laughlin, Whitney M (Chief Legal Officer); Hagan, Mark Christopher (Chief Information and Digital); Jones, Daphne E (director); Foletta, Mark G (director); Caballero, Jorge A. (director); Fontenot, Teri G. (director); Harris, R Jeffrey (director); Hinton, James H. (director); and 3 more. 13 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.